INDV FY 2018 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena

INDVIndivior Pharmaceuticals Inc

$4B

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$960M-16.4% YoY

Gross Profit

$825M86.0% margin

Operating Income

$317M33.0% margin

Net Income

$263M27.4% margin

EPS (Diluted)

$1.75

Cash Flow

Operating Cash Flow

$289M

Free Cash Flow

$250M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$1.5B

Stockholders' Equity

$66M

Cash & Equivalents

$924M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$960M	$1.1B	-16.4%
Gross Profit	$825M	$1.0B	-19.5%
Operating Income	$317M	$423M	-25.1%
Net Income	$263M	$61M	+331.1%